Evidence map›Paper›PMID 22419546›Full record

ArticlePsycho-oncology2013

Factors associated with breast cancer worry 3 years after completion of adjuvant treatment.

Kristin M Phillips, Heather L McGinty, Brian D Gonzalez, Heather S L Jim, Brent J Small, Susan Minton, Michael A Andrykowski, Paul B Jacobsen

Open access · greenAbstract read
In one paragraph

Article in Psycho-oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation.Journal of cancer survivorship : research and practice · 2016
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Change in worry over time among Hispanic women with thyroid cancer.Journal of cancer survivorship : research and practice · 2022
    Article
  8. Article
  9. Physician management of thyroid cancer patients' worry.Journal of cancer survivorship : research and practice · 2021
    Article
  10. Article
  11. Worry in Thyroid Cancer Survivors with a Favorable Prognosis.Thyroid : official journal of the American Thyroid Association · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Association of worry about cancer to benefit finding and functioning in long-term cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  17. Article
  18. Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kristin M PhillipsDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL 33612, USA.
Heather L McGinty
Brian D Gonzalez
Heather S L Jim
Brent J Small
Susan Minton
Michael A Andrykowski
Paul B Jacobsen
Moffitt Cancer Center · USUniversity of Kentucky · US

Funding

Behavioral Oncology Education & Career DevelopmentR25CA090314 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI BRANDON, THOMAS H · 2003 to 2018
$4.0M
COGNITIVE BEHAVIORAL ASPECTS OF CANCER RELATED FATIGUER01CA082822 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI JACOBSEN, PAUL B · 1999 to 2008
$3.2M
NCI NIH HHS R01 CA082822NCI NIH HHS R01CA82822NCI NIH HHS R25 CA090314
6 · The paper itself

Abstract

objectiveAlthough many survivors continue to worry about cancer years after completing treatment, little is known about factors associated with cancer worry. This study examined associations between breast cancer worry and demographic and clinical variables, as well as fatigue, symptom burden, and risk perception in a sample of breast cancer survivors 3 years post-adjuvant treatment. We hypothesized that after controlling for demographic and treatment factors, a significant proportion of variance in cancer worry would be explained by greater fatigue severity, more symptom burden, and greater perceived risk of recurrence.

methodsStage 0-II breast cancer patients (N = 202) completed measures of risk perception, cancer worry (modified Lerman's Cancer Worry Scale), symptom burden (Memorial Symptom Assessment Scale), and fatigue severity (Fatigue Symptom Inventory) 3 years after completing adjuvant treatment. Multiple regression analyses were used to determine the proportion of variance in cancer worry accounted for by fatigue, symptom burden, and risk perception after controlling for demographic and clinical variables.

resultsAge, fatigue, symptom burden, and risk perception each explained a significant proportion of variance in cancer worry (p < 0.05). Fatigue, symptom burden, and risk perception together accounted for 27% of the variance in cancer worry after controlling for demographic and clinical factors (p < 0.01).

conclusionsThe hypothesis was supported that fatigue, symptom burden, and risk perception are associated with cancer worry among breast cancer survivors. It is possible that lingering fatigue and other symptoms may remind breast cancer survivors of their disease.

Indexed as

AdultAgedAged, 80 and overAnxietyBreast NeoplasmsChemotherapy, AdjuvantFatigueFemaleHumansLongitudinal StudiesMiddle AgedNeoplasm StagingRadiotherapy, AdjuvantRegression AnalysisRisk FactorsSocioeconomic Factors

Identifiers

PMID22419546
PMCPMC3392435
OpenAlexW1490593023

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.